Authors | Sample size | Treatment duration | Symptom recurrence rates | Comparator recurrence rate | ||||
---|---|---|---|---|---|---|---|---|
9 months | 12 months | 18 months | 24 months | 36 months | ||||
Kane J et al. [24]. | 28 | Not specified | 41% | 0% | ||||
Crow T et al. [26]. | 120 | Not specified | 62% | 46% | ||||
Gitlin M et al. [21]. | 53 | 3 months in remission | 78% | 96% | - | |||
Wunderink L et al. [25]. | 161 | 6 months in remission | 43% | 21% | ||||
Chen E. et al. [22]. | 178 | 12 months + | 79% | 41% | ||||
Gaebel W. et al. [27]. | 44 | 12 months | 57% | 4% | ||||
Boonstra G. et al. [23]. | 20 | 12 months min remission | 82% | 12% | ||||
Emsley R et al. [10]. | 33 | 24 months | 79% | 94% | 97% | - |